Below are the side effects of the Provenge competitor Taxotere:
"Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); back pain; black or bloody stools; change of skin color; chest pain or tightness; decreased urination; fainting; fast, slow, or irregular heartbeat; fever, chills, or sore throat; flushing; increased or painful urination; mouth or lip sores or inflammation; red, swollen, hardened, blistered, or peeling skin; severe or persistent dizziness or headache; severe or persistent nausea, vomiting, diarrhea, or stomach pain; severe or persistent weakness or tiredness; shortness of breath; stomach swelling; sudden, unusual weight gain; swelling of the hands, feet, or ankles; swollen lymph glands; trouble swallowing; unusual bruising or bleeding; vision problems; vomit that looks like coffee grounds; warm sensation while you are receiving Taxotere; yellowing of the eyes or skin."
"Vomit that looks like coffee grounds"...OK, yeah, sign me up for that. These reactions/side effects are why many patients refused Taxotere, when it was the only available option. Now that Provenge is an available option, who would choose Taxotere???
Ongoing Provenge testing will demonstrate that Provenge works much better in earlier stages of PC...this would be true of any kind/brand of cancer vaccine.
Plus you almost always lose your hair, and your toe and finger nails can fall off too. Provenge will be the treatment of choice for its patient population once the docs have full confidence in the reimbursement schedule.